Leaps by Bayer logo

Leaps by Bayer

Crunchbase
Pitchbook
Crunchbase

Deals on record

5

Common Fundraising Type

Equity

Indapta Therapeutics develops allogeneic Natural Killer (NK) cell therapies for treating cancer and autoimmune diseases.

Equity
$22.5M
12/17/2024
Article
Nuvig Therapeutics logo
Nuvig Therapeutics

Biotechnology

Sanofi Ventures logo
Blue Owl Healthcare Opportunities logo
Norwest Venture Partners logo
Novo Holdings logo
Mission BioCapital logo
LOTTE Holdings logo
Leaps by Bayer logo
Global BioAccess Fund logo

Nuvig Therapeutics is a biotechnology company developing treatments for autoimmune diseases that do not rely on immunosuppression.

Series B
$161M
12/05/2024
Article
EarthOptics logo
EarthOptics

Soil digitization

EarthOptics specializes in soil digitization and predictive agronomy by integrating field-based sensing technologies with lab-based analysis to provide comprehensive soil data.

Equity
$24M
11/19/2024
Article
NewLeaf Symbiotics logo
NewLeaf Symbiotics

Agricultural Biotechnology

Gullspång Re:food logo
S2G Ventures logo
Otter Capital Partners logo
Leaps by Bayer logo

NewLeaf Symbiotics is an agricultural biotech firm that develops and commercializes pink-pigmented facultative methylotrophs (PPFMs) for use as biostimulants and biocontrol agents to enhance crop production and nitrogen use efficiency.

Series D
$45M
12/19/2023
Article

Series A
$6M
10/03/2023
Article